arrow
H

Hideaki Takahashi

national cancer center - japan
H指数:38
被引数:5,953

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

HER2 Intratumoral Heterogeneity in Salivary Duct Carcinoma: Association With Treatment Response and Comparison Between Primary and Metastatic Lesions

唾液腺导管癌中HER2肿瘤内异质性:与治疗反应的关系及原发灶与转移灶的比较

2026-08-270
PRE
Recommendations for generating real-world evidence with regulatory-grade relevance and reliability

关于生成具有监管级相关性和可靠性的真实世界证据的建议

2026-08-200
OAAI
Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil Therapy on Synchronous Early-Stage Oropharyngeal/Hypopharyngeal Cancer in Patients With Esophageal Cancer

食管癌患者中同步早期能否咽/下咽癌接受多西他赛、顺铂和5-氟尿嘧啶新辅助治疗的影响

2026-05-010
PRE
Feasibility of ensuring surgical margins of transoral robotic surgery for lateral oropharyngectomy for p16-positive oropharyngeal squamous cell carcinoma patients compared with non-robotic surgery: A single-center, retrospective study

经口机器人手术确保p16阳性扁桃体鳞状细胞癌患者侧咽切除术手术切缘的可行性与非机器人手术的比较:一项单中心回顾性研究

2026-01-010
PRE
The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapy

HER2-Low表达在涎腺导管癌中的影响:临床病理特征、生存结局及其与雄激素受体靶向治疗的关联

2025-06-010
PRE
PD-L1 expression as a predictive biomarker in patients with recurrent or metastatic salivary gland carcinoma treated with pembrolizumab

PD-L1表达作为使用pembrolizumab治疗的复发或转移性唾液腺癌患者的预测生物标志物

2024-08-270
OAAI
Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting

使用类器官培养和患者来源的异种移植建立实验性唾液腺癌模型

2022-12-206
OAAI
Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling

通过综合分子谱分析鉴定涎腺导管癌的新型预后和预测生物标志物

2022-11-047
OAAI
Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma

HER2-targeted或雄激素剥夺疗法在涎腺导管癌中的生存益处

2022-09-0619
OAAI
The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy

EZH2和H3K27me3表达作为涎腺导管癌患者临床预后预测指标的作用: 一项大型系列研究,重点是雄激素阻断和HER2-Targeted联合治疗的相关性

2022-02-0315
OAAI
Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma

纳武利尤单抗治疗复发和转移性涎腺癌的疗效和安全性的多中心回顾性研究

2020-10-1231
OAAI
Establishment ofPDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method

使用类器官培养方法建立pdx衍生的涎腺腺样囊性癌细胞系

2020-10-0721
OA